围手术期口服营养补充对肥胖症患者行腹腔镜袖状胃切除术后短期疗效影响的前瞻性研究

Influence of perioperative oral nutritional supplementation on short‑term efficacy of laparos-copic sleeve gastrectomy for obesity patients: a prospective study

  • 摘要:
    目的 探讨围手术期口服营养补充对肥胖症患者行腹腔镜袖状胃切除术(LSG)后短期疗效的影响。
    方法 采用前瞻性研究方法。选取2018年1月至2021年12月宁夏医科大学总医院收治的218例肥胖症行LSG患者的临床资料。患者围手术期行口服营养补充治疗设为试验组,行常规治疗设为对照组。观察指标:(1)入组患者分组情况。(2)术后及随访情况。(3)营养相关指标情况。(4)饮食依从性情况。(5)减重相关指标情况。采用电话、微信和门诊方式进行随访。患者出院后30 d随访1次,随访内容包括白蛋白(Alb)、血红蛋白(Hb)、饮食依从性情况和减重相关指标。随访时间截至2022年2月。正态分布的计量资料以x±s表示,组间比较采用独立样本t检验。偏态分布的计量资料以M(范围)表示,组间比较采用Mann‑Whitney U检验。计数资料以绝对数或百分比表示,组间比较采用χ²检验。重复测量数据采用重复测量方差分析。等级资料比较采用秩和检验。
    结果 (1)入组患者分组情况。筛选出符合条件的患者218例;男42例,女176例;年龄为(32±9)岁;体质量指数(BMI)为(39±7)kg/m2。218例患者中,试验组和对照组各109例。试验组患者性别(男、女),年龄,BMI,术前Alb,术前Hb分别为17、92例,(33±9)岁,(39±7)kg/m2,(40.6±4.8)g/L,(141.7±13.9)g/L;对照组患者上述指标分别为25、84例,(31±8)岁,(39±8)kg/m2,(40.9±4.2)g/L,(142.9±9.7)g/L;两组患者上述指标比较,差异均无统计学意义(χ²=1.89,t=-1.52、0.51、0.40、0.71,P>0.05)。(2)术后及随访情况。试验组患者首次住院时间、首次住院费用分别为(9.1±2.9)d、(3.6±0.5)万元;对照组患者上述指标分别为(11.6±3.7)d、(4.9±1.0)万元;两组患者上述指标比较,差异均有统计学意义(t=5.58,12.38,P<0.05)。218例患者中,119例获得随访,其中试验组62例、对照组57例。119例患者随访时间为31.0(25.0~38.0)d。218例患者中,14例发生术后并发症导致再入院治疗,其中试验组2例,分别为恶心呕吐1例、肠梗阻1例;对照组12例,分别为恶心呕吐10例、胃瘘2例;两组患者再入院治疗比较,差异有统计学意义(χ²=7.63,P<0.05)。14例患者再入院与首次出院时间间隔为(22.0±6.7)d。(3)营养相关指标情况。试验组62例获得随访患者术前、首次出院前、术后1个月Alb和Hb分别为(40.4±5.5)g/L、(35.9±3.8)g/L、(45.4±2.9)g/L和(140.8±13.9)g/L、(130.5±16.9)g/L、(147.8±17.2)g/L;对照组57例获得随访患者上述指标分别为(41.2±3.9)g/L、(34.2±3.9)g/L、(42.7±5.3)g/L和(143.0±9.7)g/L、(122.9±12.8)g/L、(139.0±11.4)g/L;两组患者术前至术后1个月Alb和Hb组间变化趋势比较,差异均有统计学意义(F组间=4.27,5.72,P<0.05);两组患者术前至术后1个月Alb和Hb变化趋势比较,差异均有统计学意义(F时间=187.46,85.13,P<0.05);两组患者术前至术后1个月Alb和Hb变化趋势之间均有交互效应(F交互=7.25,9.13,P<0.05)。单独效应结果显示:两组患者Alb和Hb术前干预效应比较,差异均无统计学意义(t=-0.90,-0.99,P>0.05);首次出院前、术后1个月干预效应比较,差异均有统计学意义(t=2.45,3.34,2.75,3.34,P<0.05)。(4)饮食依从性情况。试验组62例获得随访患者饮食依从性完全依从、部分依从、不依从分别为28、19、15例;对照组57例获得随访患者上述指标分别为17、16、24例;两组患者饮食依从性比较,差异有统计学意义(Z=-2.14,P<0.05)。(5)减重相关指标情况。试验组62例获得随访患者术前体质量、体脂肪、骨骼肌、体脂率、腰臀脂肪比、内脏脂肪面积分别为(111.0±23.0)kg、(50.0±15.0)kg、(34.0±7.0)kg、45%±6%、0.99±0.08、(178±53)cm2;对照组57例获得随访患者上述指标分别为(108.0±22.0)kg、(49.0±13.0)kg、(33.0±7.0)kg、45%±5%、0.98±0.09、(174±51)cm2;两组患者上述指标比较,差异均无统计学意义(t=-0.71,-0.48,-1.04,0.70,-0.80,-0.46,P>0.05)。试验组62例获得随访患者术后1个月体质量下降、体脂肪下降、骨骼肌下降、体脂率下降、腰臀脂肪比下降、内脏脂肪面积下降分别为13.8(11.8~16.5)kg、7.5(6.3~10.1)kg、3.4(2.5~4.6)kg、2.05%(1.19%~3.21%)、0.04(0.03~0.06)、31.5(24.4~41.0)cm2;对照组57例获得随访患者上述指标分别为10.8(8.5~13.1)kg、5.9(4.8~8.0)kg、4.0(3.0~5.2)kg、2.0%(0.75%~3.20%)、0.04(0.03~0.05)、29.1(21.8~37.9)cm2;两组患者体质量下降、体脂肪下降比较,差异均有统计学意义(Z=-4.99,-3.54,P<0.05),骨骼肌下降、体脂率下降、腰臀脂肪比下降、内脏脂肪面积下降比较,差异均无统计学意义(P>0.05)。
    结论 围手术期口服营养补充可减少肥胖症患者行LSG后并发症发生和再入院治疗情况,改善患者术后短期营养状况和提高减重手术疗效。

     

    Abstract:
    Objective To investigate the influence of perioperative oral nutritional supple-mentation on short‑term efficacy of laparoscopic sleeve gastrectomy (LSG) for obesity patients.
    Methods The prospective study was conducted. The clinical data of 218 obesity patients who underwent LSG in the General Hospital of Ningxia Medical University from January 2018 to December 2021 were selected. Patients receiving perioperative oral nutritional supplementation were allocated into the experiment group, and patients receiving perioperative conventional treatment were allo-cated into the control group, respectively. Observation indicators: (1) grouping situations of the enrolled patients; (2) postoperative situations and follow‑up; (3) nutrition related indicators; (4) dietary compliance; (5) weight loss related indicators. Follow‑up was conducted using telephone interview, WeChat communication and outpatient examination to detect albumin (ALB), hemoglobin (HB), dietary compliance and weight loss related indicators of patients up to February 2022. Patients were followed up once every 30 days after discharge. Measurement data with normal distribution were represented as Mean±SD, and comparison between groups was conducted using the indepen-dent sample t test. Measurement data with skewed distribution were represented as M(range), and comparison between groups was conducted using the Mann‑Whitney U test. Count data were described as absolute numbers or percentages, and comparison between groups was performed using the chi‑square test. Repeated measurement data were analyzed using the repeated ANOVA. Comparison of ordinal data was analyzed using the rank sum test.
    Results (1) Grouping situations of the enrolled patients. A total of 218 patients were selected for eligibility. There were 42 males and 176 females, aged (32±9)years with body mass index (BMI) as (39±7)kg/m2. Of the 218 patients, there were 109 patients in the experiment group and 109 patients in the control group. Gender(male, female), age, BMI, preoperative albumin (Alb), preoperative hemoglobin (Hb) were 17, 92, (33±9)years, (39±7)kg/m2, (40.6±4.8)g/L, (141.7±13.9)g/L in the experiment group, versus 25, 84, (31±8)years, (39±8)kg/m2, (40.9±4.2)g/L, (142.9±9.7)g/L in the control group, showing no signifi-cant difference in the above indicators between the two groups (χ²=1.89, t=‒1.52, 0.51, 0.40, 0.71, P>0.05). (2) Postoperative situations and follow‑up. The duration of initial hospital stay, the cost of initial hospital stay were (9.1±2.9)days, (3.6±0.5)ten thousand yuan in the experiment group, versus(11.6±3.7)days, (4.9±1.0)ten thousand yuan in the control group,showing significant differences in the above indicators between the two groups (t=5.58, 12.38, P<0.05). Of the 218 patients,119 patients were followed up,including 62 patients in the experiment group and 57 patients in the control group,with the follow up time as 31.0(range, 25.0‒38.0)days. Of the 218 patients, 14 cases were read-mitted for postoperative complications. There were 2 cases in the experiment group including 1 case with nausea and vomiting and 1 case with ileus, and there were 12 cases in the control group including 10 cases with nausea and vomiting and 2 cases with gastric fistula. There was a significant difference in the readmission between the two groups (χ²=7.63,P<0.05). The interval between readmission and initial discharge of the 14 patients was(22.0±6.7)days. (3) Nutrition related indica-tors. The Alb and Hb of the 62 patients being followed up in the experiment group were (40.4±5.5)g/L, (35.9±3.8)g/L, (45.4±2.9)g/L and (140.8±13.9)g/L, (130.5±16.9)g/L, (147.8±17.2)g/L before opera-tion, before the first discharge and one month after operation, respectively. The above indicators of the 57 patients being followed up in the control group were (41.2±3.9)g/L, (34.2±3.9)g/L, (42.7±5.3)g/L and (143.0±9.7)g/L, (122.9±12.8)g/L, (139.0±11.4)g/L before operation, before the first discharge and one month after operation, respectively. There were significant differences in change trends of Alb and Hb before operation to one month after operation between the two groups (Fgroup=4.27, 5.72, P<0.05). There were significant differences in Alb and Hb before operation to one month after operation between the two groups (Ftime=187.46, 85.13, P<0.05). There were interaction effects in change trends of Alb and Hb before operation to one month after operation between the two groups (Finteraction=7.25, 9.13, P<0.05). Results of individual effect shown that there was no significant difference in the intervention effect of Alb and Hb before operation between the two groups (t=‒0.90, ‒0.99, P>0.05), and there were significant differences in the intervention effect of Alb and Hb before the first discharge and one month after operation (t=2.45, 3.34, 2.75, 3.34, P<0.05). (4) Dietary compliance. Cases with dietary complete compliance, partial compliance, non‑compliance of the 62 patients being followed up in the experiment group were 28, 19, 15, respectively. The above indicators of the 57 patients being followed up in the control group were 17, 16, 24, respectively. There was a signifi-cant difference in the dietary compliance between the two groups (Z=‒2.14, P<0.05). (5) Weight loss related indicators. The body mass, body fat mass, skeletal muscle mass, body fat ratio, waist hip fat ratio, visceral fat area of the 62 patients being followed up in the experiment group were (111.0±23.0)kg, (50.0±15.0)kg, (34.0±7.0)kg, 45%±6%, 0.99±0.08, (178±53)cm2, respectively, before opera-tion. The above indicators of the 57 patients being followed up in the control group were (108.0±22.0)kg, (49.0±13.0)kg, (33.0±7.0)kg, 45%±5%, 0.98±0.09, (174±51)cm2, respectively, before opera-tion. There was no significant difference in the above indicators between the two groups (t=‒0.71, ‒0.48, ‒1.04, 0.70, ‒0.80, ‒0.46, P>0.05). The body mass loss, body fat mass loss, skeletal muscle mass loss, body fat ratio loss, waist hip fat ratio loss, visceral fat area loss of the 62 patients being followed up in the experiment group were 13.8(range, 11.8‒16.5)kg, 7.5(range, 6.3‒10.1)kg, 3.4(range, 2.5‒4.6)kg, 2.05%(range, 1.19%‒3.21%), 0.04(range, 0.03‒0.06), 31.5(range, 24.4‒41.0)cm2, respectively, one month after operation. The above indicators of the 57 patients being followed up in the control group were 10.8(range, 8.5‒13.1)kg, 5.9(range, 4.8‒8.0)kg, 4.0(range, 3.0‒5.2)kg, 2.0%(range, 0.75%‒3.20%), 0.04(range, 0.03‒0.05), 29.1(range, 21.8‒37.9)cm2, respectively, one month after operation. There were significant differences in the body mass loss and body fat mass loss between the two groups (Z=‒4.99, ‒3.54, P<0.05), and there was no significant difference in skeletal muscle mass loss, body fat ratio loss, waist hip fat ratio loss, visceral fat area loss between the two groups (P>0.05).
    Conclusion Perioperative supplement of oral nutritional can reduce the incidence of post-operative complications and readmission and enhance the postoperative nutritional status and short‑term efficacy of obesity patients undergoing LSG.

     

/

返回文章
返回